Unfortunately, the NPC cell lines available in our laboratory were highly resistant to olaparib (concentration ≤ 300 μmol/L), albeit PARP1 proteins were abundantly expressed (Table 1 and Figure 1A). The gene discussed is PARP1; the disease is nasopharyngeal carcinoma.